Screening and management of pretransplant cardiovascular disease

Area of Science:

• Nephrology
• Cardiology
• Transplant Surgery

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality in kidney transplant recipients.
• Accurate pre-transplant cardiac risk assessment is essential for patient selection and management.
• Optimal screening strategies for asymptomatic, high-risk candidates remain debated.

Purpose of the Study:

• To review current research on pre-transplant cardiovascular disease screening and management.
• To define the optimal approach for asymptomatic kidney transplant candidates at high risk for CVD.
• To identify research gaps and priorities in this field.

Main Methods:

• Literature review of randomized controlled trials (RCTs) and observational studies.
• Analysis of evidence regarding noninvasive stress testing and prophylactic revascularization.
• Evaluation of perioperative beta-blockade strategies.

Main Results:

• Prophylactic revascularization before major noncardiac surgery does not reduce cardiac events or improve survival.
• The utility of noninvasive stress testing in stable patients prior to major noncardiac surgery is questionable.
• Perioperative beta-blockade may benefit intermediate-to-high-risk candidates, but acute administration can be harmful.

Conclusions:

• Coronary artery disease investigation is indicated for kidney transplant candidates with symptoms of myocardial ischemia.
• Insufficient evidence supports routine cardiovascular screening in asymptomatic candidates, irrespective of risk factors.
• Further RCTs are needed to establish optimal screening protocols for renal transplant candidates.